Ashley's response to our recent paper argues that a fuller appreciation of the available clinical data, of the rights of children to autonomy, and of the primary purpose of gender-affirming endocrine treatment supports the rejection of both the pathway and consent dilemmas for the treatment of gender dysphoria, as raised in this journal. In this response, we highlight certain misrepresentations of our argument, and defend our conclusions against Ashley's main objections.

• Klíčová slova
• decision making, ethics, gender identity,
• MeSH
• dítě MeSH
• gender dysphoria * terapie   MeSH
• lidé MeSH
• osobní autonomie * MeSH
• postupy změny pohlaví * MeSH
• Check Tag
• dítě MeSH
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• komentáře MeSH